About Telesis Bio
Empowering researchers to accelerate discovery
Powering the future with synthetic biology
Telesis Bio is transforming how the world builds biology. Our flagship Gibson SOLA® platform enables on-demand, high-fidelity DNA and mRNA synthesis directly within customer labs—eliminating delays and constraints from traditional outsourcing. By combining enzymatic synthesis chemistry with standard laboratory automation and intuitive design software, Gibson SOLA gives scientists full control over their build timelines, data, and discovery pipelines.
Researchers around the globe—from top-tier biopharma to emerging biotech startups—are using Telesis Bio’s technology to accelerate breakthroughs in vaccine development, precision immunotherapy, antibody engineering, and sustainable bio-based products. We're proud to power synthetic biology innovation at scale—faster, cleaner, and more securely than ever before.
Backed by a legacy of firsts
Our team of diverse scientists, engineers and thinkers are invested in making synthetic biology broadly accessible to researchers around the world. Telesis Bio’s team of innovators, led by Dr. Dan Gibson, has been instrumental in pioneering several advances in this field – producing over 6,000+ citations and 300+ patents to date. From the industry standard Gibson Assembly method® to innovations like the first synthetic flu vaccine and the world’s only synthetic biology workstation – the BioXp® 3250, our firsts are designed to accelerate your breakthroughs.
Telesis Bio is committed to best practices in biosecurity and is a member of the International Gene Synthesis Consortium. We support researchers and the synthetic biology community with the responsible synthesis of genes for discovering and creating new medicines, diagnostic tests, agricultural biotechnology products, industrial chemicals, and other beneficial applications.